ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

KROS Keros Therapeutics Inc

60.57
3.47 (6.08%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Keros Therapeutics Inc KROS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
3.47 6.08% 60.57 09:00:00
始値 安値 高値 終値 前日終値
57.32 57.32 62.19 60.57 57.10
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/1421:00GLOBEKeros Therapeutics Announces U.S. FDA Fast Track Designation..
2024/3/0622:01EDGAR2Form 8-K - Current report
2024/3/0522:02EDGAR2Form 8-K - Current report
2024/3/0522:01EDGAR2Form 8-K - Current report
2024/3/0522:00GLOBEKeros Therapeutics to Present at Leerink Partners 2024..
2024/2/2906:02EDGAR2Form 8-K - Current report
2024/2/2906:01GLOBEKeros Therapeutics Reports Recent Business Highlights and..
2024/2/2407:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1610:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1610:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1610:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1610:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2922:00GLOBEKeros Therapeutics To Present at Pulmonary Vascular Research..
2024/1/0922:01EDGAR2Form 8-K - Current report
2024/1/0922:00GLOBEKeros Therapeutics Announces Closing of Upsized Public..
2024/1/0906:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:04EDGAR2Form 8-K - Current report
2024/1/0506:04EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0506:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/0411:29GLOBEKeros Therapeutics Announces Pricing of Upsized Public..
2024/1/0406:05GLOBEKeros Therapeutics Announces Proposed Public Offering of..
2024/1/0406:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/0322:04EDGAR2Form 8-K - Current report
2023/12/1120:02EDGAR2Form 8-K - Current report
2023/12/1120:00GLOBEKeros Therapeutics Presents Clinical Data from its KER-050..
2023/11/0722:01EDGAR2Form 8-K - Current report
2023/11/0722:00GLOBEKeros Therapeutics to Present at Upcoming Healthcare..
2023/11/0622:11EDGAR2Form 8-K - Current report
2023/11/0622:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0622:01EDGAR2Form 8-K - Current report
2023/11/0622:00GLOBEKeros Therapeutics Reports Recent Business Highlights and..
2023/11/0222:00GLOBEKeros Therapeutics to Present at the 65th American Society..
2023/10/0421:01EDGAR2Form 8-K - Current report
2023/10/0421:00GLOBEKeros Therapeutics Presents Preclinical Data from its..
2023/9/0521:02EDGAR2Form 8-K - Current report
2023/9/0521:00GLOBEKeros Therapeutics to Present at Upcoming Healthcare..
2023/8/0805:02EDGAR2Form 8-K - Current report
2023/8/0721:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0721:00EDGAR2Form 8-K - Current report
2023/8/0721:00GLOBEKeros Therapeutics Reports Recent Business Highlights and..
2023/7/2805:01GLOBECorrected: Keros Therapeutics to Host Conference Call and..
2023/7/2421:01EDGAR2Form 8-K - Current report
2023/7/2421:00GLOBEKeros Therapeutics to Host Conference Call and Webcast to..
2023/6/1221:00GLOBEKeros Therapeutics Announces Update to Participation at the..
2023/6/0919:00GLOBEKeros Therapeutics Presents Clinical Trial and Preclinical..
2023/6/0721:00GLOBEKeros Therapeutics to Present at Goldman Sach’s 44th Annual..
2023/5/2222:00GLOBEKeros Therapeutics Presents Preclinical and Clinical Data..
2023/5/1205:01GLOBEKeros Therapeutics to Present at the 28th Annual Congress of..

最近閲覧した銘柄

Delayed Upgrade Clock